Euroapi Company Header Euroapi Company Header

X

530-62-1 manufacturers and suppliers on PharmaCompass

PharmaCompass
530-62-1
Also known as: 530-62-1, N,n'-carbonyldiimidazole, Di(1h-imidazol-1-yl)methanone, N,n-carbonyldiimidazole, 1h-imidazole, 1,1'-carbonylbis-, Diimidazol-1-yl ketone
Molecular Formula
C7H6N4O
Molecular Weight
162.15  g/mol
InChI Key
PFKFTWBEEFSNDU-UHFFFAOYSA-N
FDA UNII
63A10X1FSP

1 2D Structure

530-62-1

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
di(imidazol-1-yl)methanone
2.1.2 InChI
InChI=1S/C7H6N4O/c12-7(10-3-1-8-5-10)11-4-2-9-6-11/h1-6H
2.1.3 InChI Key
PFKFTWBEEFSNDU-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CN(C=N1)C(=O)N2C=CN=C2
2.2 Other Identifiers
2.2.1 UNII
63A10X1FSP
2.3 Synonyms
2.3.1 MeSH Synonyms

1. N,n'-carbonyldiimidazole

2. N,n-carbonyldiimidazole

2.3.2 Depositor-Supplied Synonyms

1. 530-62-1

2. N,n'-carbonyldiimidazole

3. Di(1h-imidazol-1-yl)methanone

4. N,n-carbonyldiimidazole

5. 1h-imidazole, 1,1'-carbonylbis-

6. Diimidazol-1-yl Ketone

7. 1,1'-carbonylbis-1h-imidazole

8. Carbonyl Diimidazole

9. 1,1-carbonyldiimidazole

10. Cdi Crosslinker

11. N,n'-carbonylbis(imidazole)

12. 1-(1h-imidazole-1-carbonyl)-1h-imidazole

13. 1-oxomethylenebis(n-imidazole)

14. 1,1'-carbonyl Diimidazole

15. Di(imidazol-1-yl)methanone

16. Di-1h-imidazol-1-ylmethanone

17. Cdi

18. 1,1'-carbonyldiimidazol

19. Carbonyl-1,1'-diimidazole

20. Nsc 67203

21. Imidazole, 1,1'-carbonyldi-

22. 1,1'-carbonylbis(1h-imidazole)

23. Mfcd00005286

24. 63a10x1fsp

25. Methanone, Di-1h-imidazol-1-yl-

26. Nsc-67203

27. 1-(1h-imidazol-1-ylcarbonyl)-1h-imidazole

28. 1,1'-carbonylbis[1h-imidazole]

29. 1,1'-carbonyl-bis(1h-imidazole)

30. 1,1'-carbonyl-bis[1h-imidazole]

31. Carbodiimidazole

32. Ccris 2606

33. N,n'-carbonyldiimidazole (cdi)

34. Einecs 208-488-9

35. 1,1 '-carbonyldiimidazole

36. Di-imidazol-1-yl-methanone

37. Unii-63a10x1fsp

38. Ai3-60328

39. Cabonyldiimidazole

40. Carbonyidimidazole

41. Carbonyldiimidazol

42. Carbonyldimidazole

43. Carbonyidiimidazole

44. 1,1'-carbonyl Bis-1h-imidazole

45. Carbonyldiirnidazole

46. Cdl

47. Cdi, Reagent Grade

48. N,n-carbonyldimidazole

49. 1,1'carbonyldiimidazol

50. 1,1'carbonyldimidazole

51. N,n-carbonyidiimidazole

52. 1,1'carbonyldiimidazole

53. 1.1'carbonyldiimidazole

54. Diimidazol-1-ylmethanone

55. 1,1'-cabonyldiimidazole

56. 1,1'-carbonyldiimdazole

57. 1,1'-carbonyldimidazole

58. 1,1'-carbonyidimidazole

59. Di-1h-imidazolylmethanone

60. 1,1'-carbonyidiimidazole

61. 1,1'-carbonyldiimmidazol

62. 1,1'carbonyl Diimidazole

63. 1,1'carbonyl-diimidazole

64. 1,1-'carbonyldiimidazole

65. 1.1' Carbonyldiimidazole

66. 1.1'-carbonyldiimidazole

67. Diimidazol-1-yl-methanone

68. 1,1' Carbonyldiimidazole

69. Imidazole,1'-carbonyldi-

70. N,n''-carbonyldiimidazole

71. 1,1'-carbonyl-diimidazol

72. Carbonyl-1,1'-dimidazole

73. 1,1'-carbonyl Dimidazole

74. 1,1'-carbonylbisimidazole

75. 1,1' -carbonyldiimidazole

76. 1,1' Carbonyl Diimidazole

77. 1,1' Carbonyl-diimidazole

78. 1,1'- Carbonyldiimidazole

79. 1,1'-carbonyl-diimidazole

80. 1,1'-carbonyldi Imidazole

81. 1,1'-carbonyldi-imidazole

82. 1-[(1h-imidazol-1-yl)carbonyl]-1h-imidazole

83. 1.1'-carbonyl-diimidazole

84. Ec 208-488-9

85. Schembl1325

86. Nciopen2_000076

87. 1,1 '-carbonyl-diimidazole

88. Di-(imidazol-1-yl)methanone

89. 1,1'-carbonyl Di-imidazole

90. 1h-imidazole,1'-carbonylbis-

91. 1,1'-carbonyldi-1h-imidazole

92. Di-1h-imidazol-1-yl-methanone

93. 1,1'-carbonyldiimidazole-13c

94. 1,1'carbonylbis[1h-imidazole]

95. Cdi, 1,1'-carbonyldiimidazole

96. Chembl3903881

97. Dtxsid9038761

98. N,n'-carbonyl Diimidazole(cdi)

99. 1,1'-carbonylbis-1h -imidazole

100. 1,1-di-imidazol-1-yl-methanone

101. Di(1h-imidazol-1-yl) Methanone

102. Di-(1h-imidazol-1-yl)methanone

103. 1,1'-carbonylbis -1h-imidazole

104. 1,1'-carbonylbis-1 H-imidazole

105. Bdbm181135

106. 1,1'-carbonyldiimidazole, >90%

107. Bis(imidazol-1-yl) Ketone

108. Bcp01361

109. Nsc67203

110. 1,1'-carbonyl-bis-[1h-imidazole]

111. Stk917779

112. Akos000120676

113. Cdi, Purum, >=95.0% (t)

114. N,n'-carbonyldiimidazole [mi]

115. Cdi, Vetec(tm) Reagent Grade, 97%

116. Cs-w008844

117. Pb47918

118. 1,1'-(oxomethanediyl)bis-1h-imidazole

119. Bis(1h-imidazol-1-yl)methanone

120. Ac-10610

121. Bp-12399

122. Us9138393, 1?-1- Carbonylimidazole

123. Us9144538, 1'-1- Carbonylimidazole

124. Cdi, >=97.0% (t)

125. 1-(1h-imidazol-1yl-carbonyl)-1h-imidazole

126. A7728

127. Am20100298

128. Ft-0606075

129. Ft-0664272

130. Ft-0687282

131. 1-(1h-imidazol-1-yl-carbonyl)-1h-imidazole

132. 1[(1h-imidazol-1-yl)carbonyl]-1h-imidazole

133. En300-21023

134. 1-(1h-imidazol-1-ylcarbonyl)-1h-imidazole #

135. 1h-imidazole, 1-(1h-imidazol-1-ylcarbonyl)-

136. P17515

137. Q418617

138. W-200555

139. F0001-1366

140. Inchi=1/c7h6n4o/c12-7(10-3-1-8-5-10)11-4-2-9-6-11/h1-6

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 162.15 g/mol
Molecular Formula C7H6N4O
XLogP3-0.2
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count3
Rotatable Bond Count0
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area52.7
Heavy Atom Count12
Formal Charge0
Complexity166
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
24065-33-6
Rivaroxaban
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
438056-69-0
Rivaroxaban
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
161596-47-0
Rivaroxaban
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY